Cerus

$5.74
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.22 (-3.78%) As of 10:12 AM EDT today

Why Robinhood?

You can buy or sell Cerus and other stocks, options, and ETFs commission-free!

About CERS

Cerus Corp. engages in the research, development, and manufacture of biomedical and surgical products. The firm produces blood system for platelets and plasma. Read More It operates through Blood Safety segment. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA. The listed name for CERS is Cerus Corporation Common Stock.

Employees
254
Headquarters
Concord, California
Founded
1991
Market Cap
951.33M
Price-Earnings Ratio
Dividend Yield
Average Volume
1.43M
High Today
$5.90
Low Today
$5.70
Open Price
$5.85
Volume
178.40K
52 Week High
$7.94
52 Week Low
$2.71

Collections

CERS Earnings

-$0.14
-$0.09
-$0.05
$0.00
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
-$0.10 per share
Actual
Available Oct 29, After Hours

You May Also Like